2021-01-26
Description
Virtual Forum: Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence
Location: Online Via PsychU.org
Description: While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this virtual forum, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP will discuss several considerations in optimizing the treatment of patients with schizophrenia. The speakers will explore the consequences of relapse for patients with schizophrenia who discontinue medications, will discuss patient- and system-level indicators that may aid in the identification of those patients at a high potential for discontinuing antipsychotic therapy, and will address how physicians can use basic pharmacogenomics to guide dosing of antipsychotics. The virtual forum will conclude with time for questions from the audience.
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
View Flyer (PDF)Event Speakers
Henry A. Nasrallah, MD
Featured Speaker
Featured Speaker
Dr. Nasrallah is the Sydney W. Souers Professor and Chair of the Department of Psychiatry at Saint Louis University (St. Louis, MO), and he is the Editor-in-Chief of Schizophrenia Research and Current Psychiatry. He is a widely recognized neuropsychiatrist, educator, and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the National Institutes of Health, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.
Dr. Nasrallah earned his MD from the American University of Beirut, School of Medicine (Beirut, Lebanon).
Roger Sommi, PharmD, BCPP, FCCP
Featured Speaker
Featured Speaker
Dr. Roger Sommi is the Associate Dean at the UMKC School of Pharmacy at The University of Missouri, the Vice Chair in the Division of Pharmacy Practice and Administration, and a Professor of Pharmacy Practice and Psychiatry.
Walter Lawhorn, PharmD
Moderator
Moderator
Walter Lawhorn, PharmD, serves as a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. His clinical areas of expertise include: clinical pharmacy, HIV / AIDS research, medical information, literature searching and analysis, clinical trial study design, schizophrenia, and bipolar disorder.
Walter attended Valdosta State University in Valdosta, Georgia; and Mercer University School of Pharmacy in Atlanta, Georgia.